Glucocorticoid-Induced Leucine Zipper: A Promising Marker for Monitoring and Treating Sepsis.

Glucocorticoid-Induced Leucine Zipper: A Promising Marker for Monitoring and Treating Sepsis.
复制标题

糖皮质激素诱导的亮氨酸拉链:监测和治疗脓毒症的一个有前途的标记。

DOI:
10.3389/fimmu.2020.606649
复制
发表时间:
2020
影响因子:
7.3
通讯作者:
Shang Y
Shang Y
中科院分区:
医学2区
文献类型:
--
作者:
He YJ;Xu JQ;Sun MM;Fang XZ;Peng ZK;Pan SW;Zhou T;Wang YX;Shang Y

文献摘要

参考文献

被引文献

相似文献

脓毒症是一种临床综合征,由感染引起的炎症反应失调导致器官功能障碍所致。失调的炎症反应从高炎症阶段转变为低炎症或免疫抑制阶段。目前,由于大多数患者免疫反应失调的时间和重叠的个体差异,没有可用于监测复杂免疫反应和治疗脓毒症的阶段特异性分子疗法。糖皮质激素诱导的亮氨酸拉链 (GILZ) 广泛存在于多种组织中,可避免糖皮质激素抵抗 (GCR) 或不良副作用。近年来,各种炎症性疾病急性过度炎症期间GILZ下调和免疫抑制期GILZ上调的特征已得到充分证明,GILZ的保护作用在脓毒症领域受到关注。然而,GILZ 是否可以成为监测和治疗脓毒症患者的有希望的候选生物标志物仍不清楚。在这里,我们讨论 GILZ 在脓毒症和脓毒症诱导的免疫抑制中的作用。
Sepsis is a clinical syndrome that resulting from a dysregulated inflammatory response to infection that leads to organ dysfunction. The dysregulated inflammatory response transitions from a hyper-inflammatory phase to a hypo-inflammatory or immunosuppressive phase. Currently, no phase-specific molecular-based therapies are available for monitoring the complex immune response and treating sepsis due to individual variations in the timing and overlap of the dysregulated immune response in most patients. Glucocorticoid-induced leucine zipper (GILZ), is broadly present in multiple tissues and circumvent glucocorticoid resistance (GCR) or unwanted side effects. Recently, the characteristics of GILZ downregulation during acute hyperinflammation and GILZ upregulation during the immunosuppressive phase in various inflammatory diseases have been well documented, and the protective effects of GILZ have gained attention in the field of sepsis. However, whether GILZ could be a promising candidate biomarker for monitoring and treating septic patients remains unknown. Here, we discuss the effect of GILZ in sepsis and sepsis-induced immunosuppression.
DOI: 10.1056/nejmoa1214969
发表时间: 2013-04-18
期刊: The New England journal of medicine
影响因子: --
作者:
Boonen E;Vervenne H;Meersseman P;Andrew R;Mortier L;Declercq PE;Vanwijngaerden YM;Spriet I;Wouters PJ;Vander Perre S;Langouche L;Vanhorebeek I;Walker BR;Van den Berghe G
通讯作者: Van den Berghe G
DOI: 10.1016/s0092-8674(02)00817-6
发表时间: 2002-07-12
期刊: CELL
影响因子: 64.5
作者:
Bledsoe, RK;Montana, VG;Xu, HE
通讯作者: Xu, HE
DOI: 10.1007/s001340101073
发表时间: 2001-10-01
影响因子: 38.9
作者:
Beishuizen, A;Thijs, LG;Vermes, I
通讯作者: Vermes, I
DOI: 10.1182/blood-2005-07-2760
发表时间: 2006-03-01
期刊: BLOOD
影响因子: 20.3
作者:
Cohen, N;Mouly, E;Emilie, D
通讯作者: Emilie, D
DOI: 10.1016/s1074-7613(00)80398-2
发表时间: 1997-12-01
期刊: IMMUNITY
影响因子: 32.4
作者:
D'Adamio, F;Zollo, O;Riccardi, C
通讯作者: Riccardi, C